Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-25

Clinical Trial Update: Commercial Prebiotic Supplement Study [NA]

View source ↗

Summary

A clinical trial update notes a commercial prebiotic supplement study for Type 2 diabetes, with the trial status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Aberdeen | Conditions: Diabetes Mellitus, Type 2 | NA | Status: UNKNOWN